These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2438500)

  • 21. Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status: a post hoc subgroup analysis of the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations trial.
    Lewin AJ; Weir MR
    Clin Ther; 2008 Dec; 30(12):2354-65. PubMed ID: 19167594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of diltiazem on hemodynamics, plasma catecholamine and renin activity during exercise in hypertension].
    Isojima K; Takase B; Arakawa K; Shibuya T; Satomura K; Mizuno K; Kurita A; Nakamura H
    J Cardiol; 1991; 21(2):383-90. PubMed ID: 1841925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension.
    Amodeo C; Kobrin I; Ventura HO; Messerli FH; Frohlich ED
    Circulation; 1986 Jan; 73(1):108-13. PubMed ID: 3510085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the efficacy and safety of irbesartan/HCTZ combination therapy with irbesartan and HCTZ monotherapy in the treatment of moderate hypertension.
    Neutel JM; Franklin SS; Lapuerta P; Bhaumik A; Ptaszynska A
    J Hum Hypertens; 2008 Apr; 22(4):266-74. PubMed ID: 17928878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-blockade and thiazide treatment of hypertension. A double-blind randomized trail comparing doxazosin and hydrochlorothiazide.
    Grimm RH; Flack JM; Schoenberger JA; Gonzalez NM; Liebson PR
    Am J Hypertens; 1996 May; 9(5):445-54. PubMed ID: 8735175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term open evaluation of amlodipine versus hydrochlorothiazide in patients with essential hypertension.
    Rofman BA
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S94-7. PubMed ID: 2467139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of diltiazem and hydrochlorothiazide for treatment of patients 60 years of age or older with systemic hypertension.
    Leehey DJ; Hartman E
    Am J Cardiol; 1988 Dec; 62(17):1218-23. PubMed ID: 3057851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension.
    Dey HM; Soufer R; Hoffer P; Wackers FJ; Black HR
    Am J Hypertens; 1996 Jun; 9(6):598-606. PubMed ID: 8783785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive and hormonal effects of PN 200-110, a new calcium-channel blocker, in essential hypertension.
    Swartz SL
    J Clin Hypertens; 1987 Dec; 3(4):463-9. PubMed ID: 2969038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients. TROPHY Study Group.
    Weir MR; Reisin E; Falkner B; Hutchinson HG; Sha L; Tuck ML
    Am J Hypertens; 1998 Aug; 11(8 Pt 1):914-20. PubMed ID: 9715782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system.
    Dahlöf B; Herlitz H; Aurell M; Hansson L
    Am J Hypertens; 1992 Dec; 5(12 Pt 1):900-11. PubMed ID: 1337459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The determinants of response to diltiazem in hypertension.
    Shepherd AM; LeForce C; Park GD; Hoop RS; Weir S
    Clin Pharmacol Ther; 1991 Sep; 50(3):338-49. PubMed ID: 1914368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertension.
    Schoenberger JA; Glasser SP; Ram CV; McMahon SG; Vanov SK; Leibowitz DA
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1105-8. PubMed ID: 6085376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide.
    Preston RA; Norris PM; Alonso AB; Ni P; Hanes V; Karara AH
    Menopause; 2007; 14(3 Pt 1):408-14. PubMed ID: 17224857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy.
    Rhee MY; Baek SH; Kim W; Park CG; Park SW; Oh BH; Kim SH; Kim JJ; Shin JH; Yoo BS; Rim SJ; Ha JW; Doh JH; Ahn Y; Chae JK; Park JB; Kim SK; Kim CH
    Drug Des Devel Ther; 2015; 9():2847-54. PubMed ID: 26082615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerance of sustained-release diltiazem 300 mg and a diuretic in the elderly.
    Djian J; Roy M; Forette B; Lekieffre J; Luccioni R
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S51-5. PubMed ID: 1706015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diuretics versus calcium-channel blockers in systemic hypertension: a preliminary multicenter experience with hydrochlorothiazide and sustained-release diltiazem.
    Frishman WH; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H; Smith LK; Sowers J; Swartz S; Zawada E
    Am J Cardiol; 1985 Dec; 56(16):92H-96H. PubMed ID: 3907323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind study of dilevalol and captopril, both in combination with hydrochlorothiazide, in patients with moderate to severe hypertension.
    McGrath BP; Matthews PG; Louis W; Howes L; Whitworth JA; Kincaid-Smith PS; Fraser I; Scheinkestel C; MacDonald G; Rallings M
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):831-8. PubMed ID: 1703608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.